Nextech Crossover I GP S.a r.l. - 30 Jun 2025 SCHEDULE 13G/A Report for ORIC Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (ORIC)

Filing Manager
Nextech Crossover I GP S.a r.l.
Reporting Manager
Nextech Crossover I GP S.a. r.l.
Security
ORIC Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share
Symbol
ORIC
Shares outstanding
85,269,488 shares
Disclosed Ownership
7,162,637 shares
Ownership
8.4%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 16:54:59 UTC
Date of event
30 Jun 2025
SEC
View on sec.gov

Quoteable Key Fact

"Nextech Crossover I GP S.a r.l. disclosed 8.4% ownership in ORIC Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (ORIC) on 30 Jun 2025."

Quick Takeaways

  • Nextech Crossover I GP S.a r.l. filed SCHEDULE 13G/A for ORIC Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (ORIC).
  • Disclosed ownership: 8.4%.
  • Date of event: 30 Jun 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Aug 2025, 16:54.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Nextech Crossover I GP S.a. r.l. 8.4% 7,162,637 7,162,637 0 /s/ Ian Charoub By Ian Charoub, Manager
Nextech Crossover I SCSp 8.4% 7,162,637 7,162,637 0 /s/ Ian Charoub By Nextech Crossover I GP S.a r.l., its General Partner, By Ian Charoub, Manager
Ian Charoub 8.4% 7,162,637 0 7,162,637 /s/ Ian Charoub Ian Charoub
Costas Constantinides 8.4% 7,162,637 0 7,162,637 /s/ Costas Constantinides Costas Constantinides
Rocco Sgobbo 8.4% 7,162,637 7,162,637 0 /s/ Rocco Sgobbo Rocco Sgobbo